EMEBuy
Emcor
Price (1y)
Fair price check
5 different valuation methods each estimate what EME should be worth, then we compare to today's price.
- P/E multiplesFairthinks it's fairly priced — estimates $828.70, about 9% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $728.95, about 20% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $573.01, about 37% below today
- Graham (defensive)Outlierestimate looks unreliable — estimates $119.50 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $73.82 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $119.50 |
| P/E multiples(vs sector peers) | $828.70 |
| P/B multiples(vs sector peers) | $573.01 |
| EV/EBITDA(vs sector peers) | $728.95 |
| Residual Income | $73.82 |
| DCF (2-stage) | skipped |
- goodwill heavy
- extreme graham estimate
- extreme rim estimate
Median of all applicable methods (current price $913.11). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency80Strong
- ValuePrice vs fundamentals38Weak
- GrowthRevenue & earnings trajectory81Strong
- MomentumRecent price strength82Strong
- HealthBalance sheet & solvency82Strong
- ProfitabilityROE, ROA, ROIC53Decent
- TechnicalTrend & volatility signals61Decent
- RiskVolatility & drawdown profile61Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $40.58B |
| Revenue (TTM) | $17.75B |
| Net income (TTM) | $1.34B |
| Operating cash flow (TTM) | $1.19B |
| CapEx (TTM) | $115.33M |
| Free cash flow (TTM)CFO − CapEx | $1.08B |
| Total assets | $9.51B |
| Total liabilities | $5.64B |
| Stockholders' equity | $3.87B |
| Cash & equivalents | $916.42M |
| Shares outstanding | 44.44M |
| EPS (basic) | $6.85 |
| EPS (diluted) | $6.84 |
| P/E ratio (TTM) | 30.34 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-04-29
- Latest period end
- 2026-04-23
- Filing lag
- 17 days
- Missing metrics
- 3(research_and_development, inventory, short_term_debt)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.